Study of the Cabochon System for Improvement in the Appearance of Cellulite

Inclusion Criteria:

- Female, age 18-55

- moderate or severe cellulite

- BMI less than 35

- will not to try any other cellulite treatments through 12M follow-up

Exclusion Criteria:

- cellulite treatment on the thighs or buttocks in the last 90 days

- prior liposuction in the thighs or buttocks

- Greater than 10% increase or decrease in body weight within past 6 months

- evidence of active infection or a fever >38C

- current or recent smoker

- history of hypertension, diabetes or hypoglycemia

- history of coagulopathy(ies) and/or on anticoagulant medication

- history of cardiopathy or pneumopathy

- history of severe anemia

- has atrophic scars, or has a history of atrophic scars or keloids

- taken within 14 days of treatment:

- NSAIDs (e.g. aspirin, ibuprofen, naproxen)

- Vitamin E, dietary supplements (e.g. Gingko Biloba, willow bark)

- Herbal Teas

- Subject is pregnant or lactating

For Extended Follow-Up the following apply:

Inclusion Criteria:

- Subject was enrolled and treated in the CP-01-1004 study - Pivotal Study of the
Cabochon System for Improvement in the Appearance of Cellulite

- Subject understands and accepts the obligation not to try or receive any other
cellulite treatments through 3 year follow-up

Exclusion Criteria:

- Subject has undergone an injected drug, energy-based device, minimally-invasive or
invasive procedure for contouring or cellulite on the buttocks or thighs since their
12 month study follow-up visit.

- Subject has used skin care products (e.g. creams) for improvement in cellulite within
1 month prior to the follow-up visit.